|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 403/14 | |
| C07D 405/14 | |||
| A61K 31/4184 | |||
| A61P 31/12 |
| (11) | Patento numeris | 2601188 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10740116.8 |
| Europos patento paraiškos padavimo data | 2010-08-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-06-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/044356 |
| Data | 2010-08-04 |
| (87) | Numeris | WO 2012/018325 |
| Data | 2012-02-09 |
| (72) |
ROMINE, Jeffrey Lee, US
|
| (73) |
Bristol-Myers Squibb Company,
P.O. Box 4000 Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | HEPATITIS C VIRUS INHIBITORS |
| HEPATITIS C VIRUS INHIBITORS |